# Testing the Interactive Effects of Delta-9-Tetrahydrocannabinol and Pregnenolone

> **NCT02576912** · PHASE1 · COMPLETED · sponsor: **Yale University** · enrollment: 38 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Active Delta-9-THC
- **DRUG:** Active Pregnenolone
- **DRUG:** Placebo
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02576912
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2019-06-24
- **Final completion:** 2019-06-24
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2023-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02576912

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02576912, "Testing the Interactive Effects of Delta-9-Tetrahydrocannabinol and Pregnenolone". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02576912. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*